2 unknown, 1 not yet recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 1, Unknown 1 |
Follow Efgartigimod: new trials by email Literature Review of Efgartigimod trials Research Report on Efgartigimod
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EFG vs IVIG in TAMG Efgartigimod + Thymectomy, Intravenous immunglobulin + Thymectomy - Efgartigimod, Intravenous Immunoglobulin | Phase 3 | Not yet recruiting | Shanghai Zhongshan Hospital | 64 | 2025-12-01 | 2025-11-17 |
| Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders Intravenous methylprednisolone (IVMP) and Efgartigimod, IVMP - Neuromyelitis Optica, Efgartigimod | Unknown | Feng Jinzhou | 24 | 2023-11-05 | 2023-11-07 | |
| Seronegative Myasthenia Gravis - Efgartigimod IV efgartigimod - Efgartigimod, Generalized Myasthenia Gravis | Phase 3 | Unknown | University Health Network, Toronto | 30 | 2023-06-01 | 2024-09-19 |
Myasthenia Gravis (1) · Neuromyelitis Optica (1)
Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Immune System Diseases (2) · Nervous System Diseases (2) · Cranial Nerve Diseases (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Eye Diseases (1) · Myelitis, Transverse (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Neoplasms (1) · Neurodegenerative Diseases (1) · Neuromuscular Diseases (1) · Neuromuscular Junction Diseases (1)
Thymectomy (1) · efgartigimod alfa (1)
Feng Jinzhou (1) · Shanghai Zhongshan Hospital (1) · University Health Network, Toronto (1)
Canada (1) · China (1)
Jinzhou Feng, Ph.D (1) · Vera Bril, MD (1)